CN
87-99-0
Applied Filters:
Keyword:'87-99-0'
Showing 31-60 of 148 results for "87-99-0" within Technical Documents
Protocol: Rat/Mouse Ghrelin (Active)
87%
Rat
0 (Basal) 168 -- 181 --
50 218 100%
Product Information Sheet - L4149
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L2131
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L1381
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L6629
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L4129
/liter References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8,9
Product Information Sheet - L5004
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L3135
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L0906
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L3010
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L1881
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L3013
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L5629
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L5257
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Product Information Sheet - L5254
References
L3010 6:0 355.41 6 x 10-2 24
L3135 10:0 411.51 2-7 x 10-3 10,24,29
L5629 12:0 439.51 2-7 x 10-4 6,10,24,29
L6629 14:0 467.61 2-7 x 10-5 6,10,24,29
L5254 16:0 495.61 2-8 x 10-6 6,7,8
Protocol: Human GIP (Total) ELISA kit
1 0 76 76 100
49.4 125.4 111 89
148.9 224.9 200 89
444.4 520.4 481 90
2 0 58 58 100
Product Information Sheet - CKH200A
105
100-113
104
100-108
99
91-103
107
101-114
Average % of Expected 1:4
Range (%)
105
96-112
102
97-107
105
100-113
100
87-109
Product Information Sheet - MDQ1
methylation and
demethylating drugs in myelodysplastic syndromes
and secondary leukemias. Haematologica, 87,
1324-1341 (2002).
3. Beier, V., et al., Monitoring methylation changes in
cancer. Adv Biochem
An Update on Ligands for Prostanoid Receptors
is
si
o
n
s
Vo
l 2
0,
N
o.
2
,
20
04
O
rd
er
:
1-
80
0-
32
5-
30
10
Te
ch
ni
ca
MultiScreen Solvinert and MultiScreen Deep Well Solvinert Filter Plates; 96-well chemically compatible sample prep platforms
AUSTRALIA
Tel. 1 800 222 111
or (02) 9888 8999
Fax (02) 9878 0788
AUSTRIA
Tel. 0820 87 44 64
Fax 0820 87 44 44
BALTIC COUNTRIES
Tel. +358 203 05 645
Fax +358 203 05 644
BELGIUM
Tel.
Amidine-Based Catalysts (ABCs)- Design Development and Applications
, 43–98%
dr = 96:4 to 99:1
84–97% ee
PivCl (1.5 equiv)
i-Pr2NEt (4.0 equiv)
CH2Cl2, –30 oC
16 or 40 h
31c (10 mol %)
21 examples, 62–87%
dr = 80:20 to 98:2
83–99% ee
Ar2
Ar1
SARS-Cov2 anti-RBD IgG ELISA
12.5 4.8 4.2 87%
3 100 28.1 28.1
50 14.0 13.5 96%
25 7.0 6.4 92%
12.5
Effect of Membrane Filter Pore Size on Microbial Recovery and Colony Morphology
Tel. (01) 30.12.70.00
Fax (01) 30.12.71.80
GERMANY
Millipore GmbH
Hauptstraße 87
65760 Eschborn
Tel. (06196) 494-0
Fax (06196) 43901
HUNGARY
Millipore Kft.
Andor u. 47-49
1119 Budapest
Tel. 1-205
Protein Tyrosine Phosphatases- Potential Roles in Disease
d
e
r
:
1
.
8
0
0
.
3
2
5
.
3
0
1
0
(
U
S
)
T
e
c
h
n
i
c
a
l
S
Protocol
/mL) Recovery%
Plasma 1 0 0.0
2.47 2.0 80
7.41 6.1 83
22.2 19.2 87
Plasma 2 0 0.2
2.47 2.2
Using a New, Fast Flow, Low Protein Binding Membrane for Sterile Filtration in Life Science Applications
Yvelines Cedex/Tel. 01 30 12 7000/Fax 01 30 12 7180
GERMANY Millipore GmbH/Hauptstraße 87/65760 Eschborn/Tel. (06196) 494-0/Fax (06196) 43901
HUNGARY Millipore Kft./Budapest-1118/Ménesi út 23/a/Tel. 01-381
Validation and Qualification for Durapore® Sterilizing-Grade (0.22 µm) Membrane VMF4
51 11.0 4.11 90 27 13.6 7.76 109
50 11.0 4.13 89 9 13.1 7.99 102
2 10.2 4.17 118 59 14.0 >8.22 87
49 10.9 4.17 94 60 14.9 >8.22 115
48 11.0 4.21 95
Advanced Applications of Engineered Nanomaterials
nanopowder ���97�
Nickel cobalt oxide 99% 30-100 nanopowder �����0
Nickel zinc iron oxide 99+% 40-60 nanopowder ��1��9
29 Cu Copper 99.8% 0
Copper(I) oxide ~225 1.5% dispersion
Phosphine Ligand Application Guide
P CH3
• HI
671584
cataCXium® AHI 714951-87-8 486.45 X X • Arylation
N
Ph
P
t-Bu
t-Bu
672661
cataCXium® PtB 672937-61-0 287.38 X X • Dehydrogenation of iso-propanol
N
Ph
Protocol: Human Ghrelin (Active)
Recovery Rate pg/mL Recovery rate
1
0 (Basal) 325 -- 239 --
100 416 91% 338 99%
1,000
Page 2 of 5